FDA Clearance Tracker · P000040-S042
Genesys HTA System
Last checked: Nov 20, 2026Latest source record: May 26, 2022 (this decision)Source: openFDAMethods & limitations
Decided
May 26, 2022
Approved
Time to decision
29 days
Received Apr 27, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P000040-S042
- Device name
- Genesys HTA System
- Applicant
- Axora Medical, Inc.
- Applicant location
- Jacksonville, FL
- Received
- Apr 27, 2022
- Decided
- May 26, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P000040
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
Approval for manufacturing sites located at Life Science Outsourcing, Inc, 830 Challenger Street, Brea, CA 92821 and sterilization services at STERIS Applied Sterilization Technologies, 43425 Business Park Drive, Temecula, CA 92590.
Source documents
Other decisions for Axora Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260984 · Decided Aug 18, 2026 · 146 days after receipt
Device type: Hysteroscope (And Accessories) (HIH) · Obstetrics & Gynecology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.